Apretude in Thailand: First Injectable Option for HIV Pre-Exposure Prophylaxis (PrEP) Approved by the US FDA | EU Health & Wellness

Apretude in Thailand: First Injectable Option for HIV Pre-Exposure Prophylaxis (PrEP) Approved by the US FDA

10891

Apretude in Thailand, the first injectable option for HIV PrEP, is finally approved by the US Food and Drug Administration (FDA)

Apretude in Thailand: First Injectable Option for HIV Pre-Exposure Prophylaxis (PrEP) Approved by the US FDA

Apretude in Thailand, the first injectable option for HIV PrEP, is finally approved by the US Food and Drug Administration (FDA)